|Day Low/High||165.16 / 167.21|
|52 Wk Low/High||114.27 / 197.00|
Once the safest stocks in the book, the big-cap drug companies are now toxic.
The Dublin firm raised its outlook amid a delay in the launch of generic competition to its dry eye medication Restasis.
Global stocks attempted yet another rebound Tuesday, with reports of direction market intervention in China supporting prices in Asia and stronger-than-expected blue chip earnings putting European bourses on solid footing following a volatile session on Wall Street that saw a 900-point swing for the Dow Jones Industrial Average and a further worrying plunge in big-name tech companies.
My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.
Jim Cramer weighs in on Procter & Gamble, Six Flags, Western Digital, Allergan, Principal Financial Group.
Jim Cramer says somebody panicked, and their departure left behind a mess in the tech sector. But that spells a buying opportunity.
Aegon's subsidiary Transamerica today announces an agreement that would resolve litigation challenging certain monthly deduction rate adjustments on universal life insurance policies in the United States.
Straying from these names could land you in quicksand as the 4th quarter begins.
Aegon expects a one-time benefit to capital generation of approximately USD 1 billion as a result of the merger of two legal entities.
Aegon will repurchase 24,133,950 common shares to neutralize the dilutive effect of the 2018 interim stock dividend.
The entrance of more competition for Botox Cosmetic could expand the market, the drugmaker's top executive says at the Wells Fargo Healthcare Conference in Boston.
Today, US subsidiaries of Aegon reached a settlement with the Securities and Exchange Commission (SEC) in the matter of the operation and implementation of asset management quantitative models by Aegon's US asset management operations, and related...
A 'bullish perfect storm of technical factors' is powering the recent strength in large-cap pharma stocks, says Evercore ISI's Rich Ross.
Here's what you need to know now for Thursday, Aug. 23.
Let's check out the charts again so see how far this advance might carry.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGN, DSS, ENDP, ICUI, PIH, SPB, SPPI, WAAS, YRD Downgrades: BMA, BRT, ELSE, FRBK, HAE, HSKA, JD, MATW, TCMD, TSG Initiations: ALT, TRTX Read on to get TheStreet Quant Ratings' detailed report:
There's too much evidence of economic strength, so don't interpret these moves as a sign of a real slowdown.
Net income amounts to EUR 491 million supported by increase in underlying earnings Underlying earnings increase by 2% to EUR 1,064 million, or 10% on constant currencies driven by expense savings, a higher investment margin in the Netherlands, performance...
Aegon has agreed to sell its businesses in Czech Republic and Slovakia for EUR 155 million to NN Group.
The Dow Jones Industrial Average declined by 125 points on Monday.
The first is the ISE Equity Ratio which chimed in at 213%, its first reading over 200% since January 26.
This downward action in the small biotech sector tends to happen often in the 'dog days' of summer.
These names are showing technical characteristics of either bullish or bearish reversal patterns over the past week.
We are looking at today's rotation as an opportunity to pick up a high-quality name at a discount.
Botox maker Allergan's CEO is pushing back against activist investors and may get help from the company's latest earnings report.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.